ASX Market Goss Episode 27 - Leslie Chong

09/01/23 • 28 min

On this episode Tim interviews Leslie Chong, Ms Chong has 24 years of oncology experience in Phase I – III of clinical program development, including leadership role involvement in two marketed oncology products. She was previously Senior Clinical Program Lead at Genentech, Inc., in San Francisco. Genentech is widely regarded as one of the world’s most successful biotech companies with a strong oncology franchise including the best-selling breast cancer drug Herceptin.

Previous Episode

ASX Market Goss Episode 26 - Lithium Universe

On this episode Tim interviews Mr Alex Hanly, Mr Hanly has over 10 years of experience in capital delivery and operational management for publicly listed companies within the mining, oil, gas and manufacturing industries within Australia and Africa. Over the last 3 years, Mr Hanly held the role of Chief Executive Officer of ASX-listed gold company Polymetals Resources Ltd (ASX:POL). Mr Hanly was responsible for the successful IPO of the Company, the operational management and the efficient execution of the fast-track exploration strategy.Mr Hanly has a Bachelor of Mechanical Engineering and Masters of Business Administration specialising in Global Project Management.

Next Episode

ASX Market Goss Episode 28 - Peter Sinclair

On this episode Tim interviews Peter Sinclair, Peter has over 15 years of experience in providing specialist tax advisory services to clients across a range of industries and on a range of matters including corporate restructures, income tax consolidation and international tax issues.Peter has worked with a diverse range of clients including large multinationals, ASX listed corporates, large private entities, family businesses and high-net-worth individuals. Peter has a strong understanding of regulatory requirements for Australian businesses across tax legislation, accounting standards, tax lodgement deadlines, corporations law and regulatory bodies such as the Australian Securities and Investments Commission and the ASX.Peter is passionate about working with clients to achieve practical solutions that are both tax-effective and achieve the desired commercial outcomes.